Efficacy of Liposuction in the Treatment of Lipedema: A Meta-Analysis
- PMID: 38558609
- PMCID: PMC10981502
- DOI: 10.7759/cureus.55260
Efficacy of Liposuction in the Treatment of Lipedema: A Meta-Analysis
Abstract
Lipedema, a chronic and painful disorder primarily affecting women without a definitive cure, has traditionally been managed with conservative therapy, notably complete decongestive therapy, across many countries. Recently, liposuction has been explored as a potential surgical treatment, prompting this study to evaluate its effectiveness as possibly the first-line therapy for lipedema. Through extensive literature searches in databases such as CrossRef, Web of Science, PubMed, and Google Scholar up to December 2023, and using the Newcastle-Ottawa Scale for quality assessment, the study selected seven studies for inclusion. Results showed significant post-operative improvements in spontaneous pain, edema, bruising, mobility, and quality of life among lipedema patients undergoing liposuction. However, over half of the patients still required conservative therapy after surgery. Despite these promising results, the study suggests caution due to lipedema's complexity, significant reliance on self-reported data, and limitations of the studies reviewed. Thus, while liposuction may offer symptomatic relief, it should be considered an adjunct, experimental therapy rather than a definitive cure, emphasizing the need for a comprehensive approach to care.
Keywords: large-volume liposuction; lipedema; liposuction; liposuction complication; meta-analysis.
Copyright © 2024, Amato et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Lipedema: an overview of its clinical manifestations, diagnosis and treatment of the disproportional fatty deposition syndrome - systematic review. Forner-Cordero I, Szolnoky G, Forner-Cordero A, Kemény L. Clin Obes. 2012;2:86–95. - PubMed
-
- Liposuction for the treatment of lipedema: a review of clinical effectiveness and guidelines. Peprah K, MacDougall D. https://europepmc.org/article/nbk/nbk545818?report=printable&client=bot&... Canadian Agency for Drugs and Technologies in Health. 2019 - PubMed
-
- Lipedema prevalence and risk factors in Brazil. Amato AC, Amato FC, Amato JL, Benitti DA. https://www.scielo.br/j/jvb/a/Q9yR3XdzXVbrsB37KQD3mfg/?lang=en# J Vasc Bras. 2022;21:0. - PMC - PubMed
-
- First Dutch guidelines on lipedema using the international classification of functioning, disability and health. Halk AB, Damstra RJ. Phlebology. 2017;32:152–159. - PubMed
Publication types
LinkOut - more resources
Full Text Sources